04-Nov-2026 17:44:24
GUJTHEM : CLARIFIES PREFERENTIAL ISSUE TIMELINE AND UBO NAMES
12-month utilisation window for issue proceeds runs from date of allotment; UBOs disclosed for Special Situation India Fund, India Special Assets Fund III and…
Latest market headlines for GUJTHEM on Terminal.
04-Nov-2026 17:44:24
12-month utilisation window for issue proceeds runs from date of allotment; UBOs disclosed for Special Situation India Fund, India Special Assets Fund III and…
18-Sept-2026 10:31:52
• Gujarat Themis Biosyn's wholly owned subsidiary, Themis Biosyn Japan Limited, has completed the acquisition of 100% equity shareholding in MicroBiopharm Japa…
25-Aug-2026 23:31:21
• Board considered and approved the preliminary placement document and draft application form for the QIP. • Authorized opening of the proposed issue of Equity…
02-Jul-2026 11:32:18
• Sachin D. Patel, promoter, to acquire up to 5,25,000 equity shares from Pharmaceutical Business Group (India) Limited. • Proposed acquisition date is July 8-…
02-Jul-2026 09:40:05
• Sachin D. Patel to acquire up to 5,25,000 equity shares from Pharmaceutical Business Group (India) Limited. • The transaction is an inter-se transfer between…
01-Jul-2026 11:15:24
• Acquired 24,97,190 equity shares at ₹400.45 per share. • Transaction is an inter-se transfer among the promoter and promoter group. • Post-acquisition, Sachi…
26-Jun-2026 19:55:52
GUJARAT THEMIS BIOSYN LIMITED : INITIATES ARBITRATION AGAINST OPTIMUS DRUGS FOR BREACH OF SUPPLY AGREEMENT
24-Jun-2026 13:25:37
• Sachin D. Patel proposes to acquire equity shares of the Company from Themis Medicare Limited. • The acquisition is an inter-se transfer between Promoter / P…
24-Jun-2026 12:01:49
• Sachin D. Patel, Promoter/Promoter Group, proposes to acquire equity shares from Themis Medicare Limited. • Proposed acquisition date: June 30, 2026, to July…